Lv1
30 积分 2025-01-14 加入
In vivo CAR engineering for immunotherapy
1天前
已完结
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India
2个月前
已完结
ADVANCEMENTS IN CLOSED AND AUTOMATED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL MANUFACTURING UTILIZING THE MILTENYI CLINIMACS PRODIGY SYSTEM: ENABLING COST-EFFECTIVE NEXT-GENERATION THERAPIES
3个月前
已完结
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration
3个月前
已完结
Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications
4个月前
已完结
皖公网安备34019202002308
